ESMO22 Expert report on immune checkpoint inhibitors for dMMR Colorectal Cancer | OncologyPRO
Click here for Cancer Care Advice
FIGHT AGAINST CANCER - Cancer is one of the leading causes of mortality now days. The incidence trend indicates that 1 in 3 people on this planet will be affected by cancer . This calls for breakthrough research in areas of therapeutics and biomarkers. Disclosure : The views expressed are that of the author /owner of the blog only.
No comments:
Post a Comment